The Combination of Inhaled Budesonide/Formoterol and Ambroxol in Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Guoliang Zhang
Abstract
Guoliang Zhang
Abstract
Objective To investigate the effect of combination therapy with inhaled budesonide /formoterol and ambroxol on the acute exacerbations of chronic obstructive pulmonary disease(AECOPD).Methods 84 subjects with AECOPD were randomly divided into 3 groups:the control group(C group, n=28),the Budesonide/ formoterol group(B group,n=28),and the Budesonide/ formoterol and ambroxol group(A group,n=28).Compare the difference of 3 groups at the pulmonary function(FEV_1,FEV_1%、FEV_1/FVC) and the scores of SGRQ before and after the therapy.Results The pulmonary function and the scores of SGRQ in 3 groups after the therapy were improved in evidence(P0.05).Compared with control group,significantly greater improvements were seen in B group and A group(P0.05).And A group were slightly better than B group(P0.05).Conclusions This study demonstrated that combination treatment with budesonide/formoterol plus ambroxol is an effective methods in the management of AECOPD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of combination therapy with inhaled budesonide /formoterol and ambroxol on the acute exacerbations of chronic obstructive pulmonary disease(AECOPD).Methods 84 subjects with AECOPD were randomly divided into 3 groups:the control group(C group, n=28),the Budesonide/ formoterol group(B group,n=28),and the Budesonide/ formoterol and ambroxol group(A group,n=28).Compare the difference of 3 groups at the pulmonary function(FEV_1,FEV_1%、FEV_1/FVC) and the scores of SGRQ before and after the therapy.Results The pulmonary function and the scores of SGRQ in 3 groups after the therapy were improved in evidence(P0.05).Compared with control group,significantly greater improvements were seen in B group and A group(P0.05).And A group were slightly better than B group(P0.05).Conclusions This study demonstrated that combination treatment with budesonide/formoterol plus ambroxol is an effective methods in the management of AECOPD.
Key concepts: Medicine, Budesonide, Formoterol, Ambroxol, Budesonide/formoterol, Pulmonary function testing, Pulmonary disease, Anesthesia